Trial Profile

A Phase III, Randomized, Multicentre, Open-Label, Concentration-Controlled, Safety and Efficacy Study of Voclosporin and Tacrolimus in Renal Transplantation.

Status: Withdrawn prior to enrolment

Phase of Trial: Phase III

Latest Information Update: 09 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Voclosporin (Primary) ; Tacrolimus
Indications Renal transplant rejection
Focus Registrational; Therapeutic Use
Acronyms INSPIRE
Sponsors Aurinia Pharmaceuticals

Most Recent Events

16 Jan 2014 According to ClinicalTrials.gov record, status changed from not yet recruiting to withdrawn prior to recruitment.
26 Nov 2012 Commencement for this trial has been cleared by the US FDA, according to an Isotechnika media release. Patient recruitment is expected to launch in the first half of 2013.
11 Sep 2012 Planned End Date changed from 1 Jun 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com